Page last updated: 2024-12-07
2,6-diformyl-p-cresol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 81744 |
CHEMBL ID | 3904097 |
SCHEMBL ID | 546033 |
MeSH ID | M000609702 |
Synonyms (41)
Synonym |
---|
einecs 230-768-4 |
v6r37r6au3 , |
nsc 243727 |
unii-v6r37r6au3 |
nsc-243727 |
nsc243727 |
inchi=1/c9h8o3/c1-6-2-7(4-10)9(12)8(3-6)5-11/h2-5,12h,1h |
1,3-benzenedicarboxaldehyde, 2-hydroxy-5-methyl- |
7310-95-4 |
2-hydroxy-5-methylisophthalaldehyde |
2-hydroxy-5-methyl-1,3-benzenedicarboxaldehyde, 97% |
2,6-diformyl-4-methylphenol |
H0683 |
2-hydroxy-5-methylbenzene-1,3-dicarbaldehyde |
AKOS004121076 |
A19108 |
2-hydroxy-5-methyl-1,3-benzenedicarboxaldehyde |
2-hydroxy-5-methylisophthaldehyde |
FT-0636429 |
SCHEMBL546033 |
11N-961 |
2-hydroxy-5-methylisophtalaldehyde |
5-methyl-2-hydroxy-1,3-benzenedicarboxaldehyde |
DTXSID60223374 |
diformylcresol |
W-203663 |
2-hydroxy-5-methyl-benzene-1,3-dicarbaldehyde |
mfcd00016596 |
2-hydroxy-5-methylisophthalaldehyd |
bdbm202537 |
us9241942, 3-8 |
CHEMBL3904097 |
YSZC437 |
CS-0130433 |
2,6-diformyl-p-cresol |
4-methyl-2,6-diformylphenol |
2,6-diformyl-4-cresol |
3-formyl-5-methylsalicylaldehyde |
isophthalaldehyde, 2-hydroxy-5-methyl- |
2-hydroxy-5-methyl-1,3-benzenedicarboxyaldehyde |
SY050293 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.98
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.98) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |